CNS Disease in ALK-Positive NSCLC_ Monitoring and Systemic vs. Radiation Therapy [720p]
Dr. Ross Camidge, University of Colorado, discusses management of CNS progression for ALK-positive NSCLC including monitoring frequency and preferences between systemic and radiation therapy.
Author: cancergrace
Added: 05/16/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts